104 related articles for article (PubMed ID: 9086513)
1. The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain.
Bachurin SO; Shevtzova EP; Lermontova NN; Serkova TP; Ramsay RR
Neurotoxicology; 1996; 17(3-4):897-903. PubMed ID: 9086513
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
Kindt MV; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
[TBL] [Abstract][Full Text] [Related]
3. MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport.
Desai VG; Feuers RJ; Hart RW; Ali SF
Brain Res; 1996 Apr; 715(1-2):1-8. PubMed ID: 8739616
[TBL] [Abstract][Full Text] [Related]
4. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
5. TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain.
Bringmann G; God R; Feineis D; Janetzky B; Reichmann H
J Neural Transm Suppl; 1995; 46():245-54. PubMed ID: 8821061
[TBL] [Abstract][Full Text] [Related]
6. [Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].
Mizuno Y
Rinsho Shinkeigaku; 1989 Dec; 29(12):1494-6. PubMed ID: 2698296
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
8. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
[TBL] [Abstract][Full Text] [Related]
9. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP.
Samantaray S; Knaryan VH; Butler JT; Ray SK; Banik NL
J Neurochem; 2008 Mar; 104(5):1309-20. PubMed ID: 18036149
[TBL] [Abstract][Full Text] [Related]
11. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.
Nwanze E; Souverbie F; Jonsson G; Sundström E
Neurotoxicology; 1995; 16(3):469-77. PubMed ID: 8584278
[TBL] [Abstract][Full Text] [Related]
12. Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum.
Fabre E; Monserrat J; Herrero A; Barja G; Leret ML
J Physiol Biochem; 1999 Dec; 55(4):325-31. PubMed ID: 10731084
[TBL] [Abstract][Full Text] [Related]
13. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism].
Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP
Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166
[TBL] [Abstract][Full Text] [Related]
15. [The bases of MPTP neurotoxicity].
Dostert P; Strolin Benedetti M
Encephale; 1988; 14(6):399-412. PubMed ID: 3068045
[TBL] [Abstract][Full Text] [Related]
16. Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine.
Virmani A; Gaetani F; Binienda Z; Xu A; Duhart H; Ali SF
Ann N Y Acad Sci; 2004 Oct; 1025():267-73. PubMed ID: 15542726
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Staal RG; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
[TBL] [Abstract][Full Text] [Related]
18. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.
Chen LJ; Gao YQ; Li XJ; Shen DH; Sun FY
J Pineal Res; 2005 Aug; 39(1):34-42. PubMed ID: 15978055
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes as the site for bioactivation of neurotoxins.
Di Monte DA; Royland JE; Irwin I; Langston JW
Neurotoxicology; 1996; 17(3-4):697-703. PubMed ID: 9086491
[TBL] [Abstract][Full Text] [Related]
20. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice.
Shepherd KR; Lee ES; Schmued L; Jiao Y; Ali SF; Oriaku ET; Lamango NS; Soliman KF; Charlton CG
Pharmacol Biochem Behav; 2006 Mar; 83(3):349-59. PubMed ID: 16580056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
